(Discontinued) 040-000-151 Methotrexate, CAS 59-05-2

About This Item

Catalog No.
040-000-151

Discontinued

Synonyms (+)-Amethopterin; (+)-4-Amino-10-methylfolic acid; N-(p-(((2,4-Diamino-6-pteridinyl)methyl)methylamino)benzoyl)-L-glutamic acid
Keywords Rheumatoid arthritis, folic Acid antagonist, antineoplastic
Related products Licochalcone A, Formononetin,   10-Deacetylbaccatin III, Pyrroloquinoline Quinone

Quantity

kg

Technical Service

Need help? Our team of experienced scientists is here for you.

Description

Methotrexate Specifications


Product Name Methotrexate
CAS Registry Number 59-05-2
Molecular Formula C20H22N8O5
Molecular Weight 454.44
Purity ≥99%
Appearance Orange or yellow powder
Package 1kg-25kg
Solubility Almost insoluble in water, ethanol, chloroform or ether; soluble in dilute alkali solution, dissolved in dilute hydrochloric acid
Shelf life 2 years
Functions Anti-cancer, anti-Rheumatoid arthritis

Methotrexate Description


Methotrexate was first used to fight cancer and was less toxic than other treatments. It can inhibit DNA synthesis, so it can be good medicine for cancer.

Methotrexate is a cell cycle blocker with different effects. In the late G1 / S phase, methotrexate blocks the cell cycle and therefore inhibits the synthesis of DNA, RNA, thymidine and proteins. In the past, inhibiting the enzymes involved in purine metabolism, leading to the accumulation of adenosine, or inhibiting the expression of intercellular adhesion molecules on T cells, is the main mechanism of action of methotrexate. Previous studies have observed that this compound irreversibly inhibits dihydrofolate reductase (DHFR) and thymidine synthase (TS). Methotrexate has been shown to regulate inflammation by promoting adenosine release or inhibiting the transmethylation response. In adherent splenocytes, methotrexate reduces IL-1 production.

Methotrexate Application


·Raw material of early rheumatoid drugs
·Raw materials of anti-cancer drugs
·For a variety of acute leukemia, chorionic epithelial cell carcinoma, malignant mole and psoriasis

Reviews

5 Stars
2
4 Stars
0
3 Stars
0
2 Stars
0
1 Stars
0
Write a review

Get a Quote

Send us an inquiry now to find out more information and the latest prices, thanks!
Product Name
Quantity
Name
Email
Phone
Company
Application
Country
United States
  • United States
  • Afghanistan
  • Aland Islands
  • Albania
  • Algeria
  • American Samoa
  • Andorra
  • Angola
  • Anguilla
  • Antarctica
  • Antigua and Barbuda
  • Argentina
  • Armenia
  • Aruba
  • Australia
  • Austria
  • Azerbaijan
  • Bahamas
  • Bahrain
  • Bangladesh
  • Barbados
  • Belarus
  • Belgium
  • Belize
  • Benin
  • Bermuda
  • Bhutan
  • Bolivia
  • Bosnia and Herzegovina
  • Botswana
  • Bouvet Island
  • Brazil
  • British Indian Ocean Territory
  • British Virgin Islands
  • Brunei
  • Bulgaria
  • Burkina Faso
  • Burundi
  • Cambodia
  • Cameroon
  • Canada
  • Cape Verde
  • Cayman Islands
  • Central African Republic
  • Chad
  • Chile
  • China
  • Christmas Island
  • Cocos (Keeling) Islands
  • Colombia
  • Comoros
  • Congo
  • Cook Islands
  • Costa Rica
  • Croatia
  • Cuba
  • Cyprus
  • Czech Republic
  • Democratic Republic of Congo
  • Denmark
  • Disputed Territory
  • Djibouti
  • Dominica
  • Dominican Republic
  • East Timor
  • Ecuador
  • Egypt
  • El Salvador
  • Equatorial Guinea
  • Eritrea
  • Estonia
  • Ethiopia
  • Falkland Islands
  • Faroe Islands
  • Federated States of Micronesia
  • Fiji
  • Finland
  • France
  • French Guyana
  • French Polynesia
  • French Southern Territories
  • Gabon
  • Gambia
  • Georgia
  • Germany
  • Ghana
  • Gibraltar
  • Greece
  • Greenland
  • Grenada
  • Guadeloupe
  • Guam
  • Guatemala
  • Guinea
  • Guinea-Bissau
  • Guyana
  • Haiti
  • Heard Island and Mcdonald Islands
  • Honduras
  • Hong Kong
  • Hungary
  • Iceland
  • India
  • Indonesia
  • Iran
  • Iraq
  • Iraq-Saudi Arabia Neutral Zone
  • Ireland
  • Israel
  • Italy
  • Ivory Coast
  • Jamaica
  • Japan
  • Jordan
  • Kazakhstan
  • Kenya
  • Kiribati
  • Kuwait
  • Kyrgyzstan
  • Laos
  • Latvia
  • Lebanon
  • Lesotho
  • Liberia
  • Libya
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Macau
  • Macedonia
  • Madagascar
  • Malawi
  • Malaysia
  • Maldives
  • Mali
  • Malta
  • Marshall Islands
  • Martinique
  • Mauritania
  • Mauritius
  • Mayotte
  • Mexico
  • Moldova
  • Monaco
  • Mongolia
  • Montenegro
  • Montserrat
  • Morocco
  • Mozambique
  • Myanmar
  • Namibia
  • Nauru
  • Nepal
  • Netherlands Antilles
  • Netherlands
  • New Caledonia
  • New Zealand
  • Nicaragua
  • Niger
  • Nigeria
  • Niue
  • Norfolk Island
  • North Korea
  • Northern Mariana Islands
  • Norway
  • Oman
  • Pakistan
  • Palau
  • Palestinian Territories
  • Panama
  • Papua New Guinea
  • Paraguay
  • Peru
  • Philippines
  • Pitcairn Islands
  • Poland
  • Portugal
  • Puerto Rico
  • Qatar
  • Reunion
  • Romania
  • Russia
  • Rwanda
  • Saint Helena and Dependencies
  • Saint Kitts and Nevis
  • Saint Lucia
  • Saint Pierre and Miquelon
  • Saint Vincent and the Grenadines
  • Samoa
  • San Marino
  • Sao Tome and Principe
  • Saudi Arabia
  • Senegal
  • Serbia
  • Seychelles
  • Sierra Leone
  • Singapore
  • Slovakia
  • Slovenia
  • Solomon Islands
  • Somalia
  • South Africa
  • South Georgia and South Sandwich Islands
  • South Korea
  • Spain
  • Spratly Islands
  • Sri Lanka
  • Sudan
  • Suriname
  • Svalbard and Jan Mayen
  • Swaziland
  • Sweden
  • Switzerland
  • Syria
  • Taiwan
  • Tajikistan
  • Tanzania
  • Thailand
  • Togo
  • Tokelau
  • Tonga
  • Trinidad and Tobago
  • Tunisia
  • Turkey
  • Turkmenistan
  • Turks And Caicos Islands
  • Tuvalu
  • US Virgin Islands
  • Uganda
  • Ukraine
  • United Arab Emirates
  • United Kingdom
  • United States
  • United States Minor Outlying Islands
  • Uruguay
  • Uzbekistan
  • Vanuatu
  • Vatican City
  • Venezuela
  • Vietnam
  • Wallis and Futuna
  • Western Sahara
  • Yemen
  • Zambia
  • Zimbabwe
Comments
I would like to join the mailing list to receive updates from Stanford Chemicals.
Check Code